BEL shares in focus as PSU receives orders worth Rs 648 crore since late August. What’s ahead after 183% rally in 3 years?

Bharat Electronics Ltd. (BEL), a state-owned aerospace and defense electronics company, has bolstered its order book for the 2024 fiscal year with new contracts totaling ₹648.78 crore secured since late August. This recent inflow brings the company's cumulative orders for the current fiscal year to ₹11,388 crore, reinforcing its strong revenue pipeline.

Key Domestic Defense Contracts

The largest component of the new agreements is a ₹384 crore order from the Indian Air Force. This contract is for the supply of a radar warning receiver and a missile approach warning system, critical components for aircraft survivability. Additionally, the company received a ₹103 crore order from the Defence Research and Development Organisation (DRDO) for a low-band jammer, highlighting its role in developing advanced electronic warfare systems.

Expanding Export Footprint

Beyond its domestic commitments, BEL also secured export orders valued at ₹161.78 crore. These international contracts underscore the company's growing presence in the global defense market and its alignment with India's strategic push to increase defense exports.

Financial Health and Market Performance

The consistent order wins are reflected in BEL's solid financial performance. For the first quarter of fiscal 2024, the company reported a 23% year-over-year increase in consolidated net profit to ₹530.84 crore, with revenue from operations growing by 12.5% to ₹3,666.75 crore. Despite this fundamental strength, BEL's shares recently experienced a minor downturn, falling over 2% on September 15. However, this short-term volatility contrasts with its robust long-term growth, which has seen the stock rally 183% over the past three years.

Analyst Outlook

Market analysts maintain a positive outlook on the company. Brokerages including ICICI Securities and HDFC Securities have issued 'buy' ratings, with target prices set at ₹155 and ₹152, respectively. These recommendations are supported by the company’s healthy order book and consistent execution. The stock's Relative Strength Index (RSI) stands at a balanced 60.9, suggesting it is neither overbought nor oversold.